Influence of ibuprofen-arginine on serum levels of nitric oxide metabolites in patients with chronic lower back pain: a single-blind, placebo-controlled pilot trial
Completed
- Conditions
- ower back painInjury, Occupational Diseases, PoisoningLower back pain
- Registration Number
- ISRCTN18723747
- Lead Sponsor
- Zambon Svizzera S.A. (Switzerland)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Non-specific chronic lower back pain (Visual Analogue Scale [VAS] greater than or equal to 60).
Exclusion Criteria
Specific lower back pain.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method